South Korea Biotechnology Market Size, Share, By Technology (Natural Resources & Environment, Food & Agriculture, Health, Industrial Processing, and Bioinformatics), By Application (Fermentation, Chromatography, DNA Sequencing, Cell-Based Assay, PCR Technology, Nanobiotechnology, and Others), South Korea Biotechnology Insights, Industry Trend, Forecasts to 2035.
Industry: Healthcare
South Korea Biotechnology Insights Forecasts to 2035
- South Korea Biotechnology Market Size 2024: USD 25.6 billion
- South Korea Biotechnology Market Size 2035: USD 81.6 billion
- South Korea Biotechnology Market CAGR 2024: 18.3%
- South Korea Biotechnology Market Segments: Technology and Application
Get more details on this report -
The France Biotechnology Market describes an industry that develops and sells biological technologies that solve problems in healthcare and agriculture, industrial processing, and environmental protection throughout France.
Celltrion established Celltrion BioSolutions as a contract development and manufacturing organization (CDMO) to enhance its worldwide biopharmaceutical development and production capabilities.
The France biotechnology market will experience growth through biosimilar products, and personalized medicine development, agricultural biotechnology expansion, vaccine development, bioinformatics growth and research and manufacturing expansion through foreign investment.
Market Dynamics of the South Korea Biotechnology Market:
The South Korea biotechnology market is driven by improved biopharmaceutical research funding and rising biologics and biosimilar demand, agricultural biotechnology research expansion, effective public-private partnership programs and government-backed innovation initiatives. The market experiences growth because of increased healthcare requirements, which drive advancements in genetic research.
The South Korea biotechnology market is restrained by expensive research and development operations and its need to follow complicated regulatory systems, the difficulty in finding qualified employees and its reliance on outside sources for raw materials and modern laboratory equipment.
The future of the South Korea biotechnology market is bright and promising, with The personalized medicine field, biosimilar development, agricultural biotechnology innovations and foreign investment growth and domestic production capacity development all working together to create sustainable growth.
South Korea Biotechnology Market Report Coverage
| Report Coverage | Details |
|---|---|
| Base Year: | 2024 |
| Market Size in 2024: | USD 25.6 Billion |
| Forecast Period: | 2024-2035 |
| Forecast Period CAGR 2024-2035 : | CAGR Of 18.3% |
| 2035 Value Projection: | USD 81.6 Billion |
| Historical Data for: | 2020-2023 |
| No. of Pages: | 240 |
| Tables, Charts & Figures: | 105 |
| Segments covered: | By Application, By Technology |
| Companies covered:: | Celltrion Alteogen Samsung Bioepis SK Biopharmaceuticals SK Bioscience Hanmi Pharmaceutical Yuhan Corporation LG Chem Others Key Players |
| Pitfalls & Challenges: | COVID-19 Empact, Challenge, Future, Growth, & Analysis |
Get more details on this report -
Market Segmentation
The South Korea biotechnology market share is classified into technology and application.
By Technology:
The South Korea Biotechnology Market Size is divided by technology into natural resources & environment, food & agriculture, health, industrial processing, and bioinformatics. Among these, the health segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The strong biopharmaceutical demand, together with vaccine needs, biosimilar requirements and increasing healthcare biotechnology investments drove this development.
By Application:
The South Korea Biotechnology Market Size is divided by application into fermentation, chromatography, DNA sequencing, cell-based assay, PCR technology, nanobiotechnology, and others. Among these, the fermentation segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The substance has extensive applications because it is used in the production of biologics, antibiotics and vaccines, and industrial biotechnology products.
Competitive Analysis:
The report offers the appropriate analysis of the key organisations/companies involved within the South Korea biotechnology market, along with a comparative evaluation primarily based on their Category offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes Category development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Key Companies in South Korea Biotechnology Market:
- Celltrion
- Alteogen
- Samsung Bioepis
- SK Biopharmaceuticals
- SK Bioscience
- Hanmi Pharmaceutical
- Yuhan Corporation
- LG Chem
- Others
Key Target Audience
- Market Players
- Investors
- End Users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at the South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea biotechnology market based on the below-mentioned segments:
South Korea Biotechnology Market, By Technology
- Natural resources & Environment
- Food & Agriculture
- Health
- Industrial Processing
- Bioinformatics
South Korea Biotechnology Market, By Application
- Fermentation
- Chromatography
- DNA Sequencing
- Cell Based
- PCR Technology
- Nanobiotechnology
- Others
Frequently Asked Questions (FAQ)
-
What is the South Korea biotechnology market size?South Korea biotechnology market is expected to grow from USD 25.6 billion in 2024 to USD 81.6 billion by 2035, growing at a CAGR of 18.3% during the forecast period 2025-2035
-
What are the key growth drivers of the market?by improved biopharmaceutical research funding and rising biologics and biosimilar demand, agricultural biotechnology research expansion, effective public-private partnership programs and government-backed innovation initiatives. The market experiences growth because of increased healthcare requirements, which drive advancements in genetic research.
-
What factors restrain the South Korea biotechnology market?Constraints include by expensive research and development operations and its need to follow complicated regulatory systems, the difficulty in finding qualified employees and its reliance on outside sources for raw materials and modern laboratory equipment
-
How is the market segmented by technology?The market is segmented into natural resources & environment, food & agriculture, health, industrial processing, and bioinformatics.
-
Who are the key players in the South Korea biotechnology market?Key companies include Celltrion, Alteogen, Samsung Bioepis, SK Biopharmaceuticals, SK Bioscience, Hanmi Pharmaceutical, Yuhan Corporation, LG Chem, and others.
-
Who are the target audiences for this market report?The report targets market players, investors, End Users, government authorities, consulting and research firms, venture capitalists, and value-added resellers (VARs).
Need help to buy this report?